About Anzil Meditech Private Limited
Data last updated:
Anzil Meditech Private Limited is a private limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the engineering design and consultancy segment of the engineering sector. It was incorporated on 20 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U93090UP2018PTC101146.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rubi and Rajesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 471 Arun Vihar, Sec 29 Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.04 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.05 Cr (net margin 51.2%) and EBITDA of ₹1.48 Cr (EBITDA margin 72.4%). Revenue has grown at a compounded annual rate (CAGR) of 92% over three years.
The company is associated with 1 brand: Anzil. As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anzil.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressFlat No. 471 Arun Vihar, Sec 29 Noida, Uttar Pradesh, India – 201301
- IndustryEngineering, Engineering Design & Consultancy
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Anzil Meditech Private Limited
The main business activity of Anzil Meditech is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Anzil Meditech Private Limited FY 2025 filings available
Anzil Meditech Private Limited reported revenue of ₹2.04 Cr (up 217% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Anzil Meditech Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 92% over three years, including 217% growth in the latest year. EBITDA rose 456% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Anzil Meditech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.48 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.05 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Anzil Meditech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 72.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 51.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Anzil Meditech are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Anzil Meditech Private Limited
Anzil Meditech Private Limited is audited by K P O & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K P O & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Anzil Meditech Private Limited
Anzil Meditech has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rubi | Director | 20 Feb 2018 | 8 Years 7 Months | Current |
| Rajesh Kumar Also directs: Bhargas India Private Limited | Director | 20 Feb 2018 | 8 Years 7 Months | Current |
| Veerwala | Director | 20 Feb 2018 | 8 Years 7 Months | Current |
Ownership and Shareholding of Anzil Meditech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Anzil Meditech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2023 | Hdfc Bank Limited | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Anzil Meditech Private Limited
Employment history and EPFO contributions of people linked to Anzil Meditech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Anzil Meditech Private Limited
Anzil Meditech Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Rajesh Kumar was appointed as Director on 20 Feb 2018.
Credit Ratings, Litigation & Regulatory Alerts for Anzil Meditech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Anzil Meditech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Anzil Meditech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Anzil Meditech Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Anzil Meditech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anzil Meditech Private Limited
Anzil Meditech is an active private limited company based in Noida, Uttar Pradesh, India. The company works in engineering design and consultancy, within the engineering industry. It was incorporated on 20 February 2018 (8+ years old) and is registered under CIN U93090UP2018PTC101146.
Anzil Meditech reported revenue of ₹2.04 Cr for FY 2025 (up 217% YoY).
Anzil Meditech has 3 current directors:
- Rubi - Director
- Rajesh Kumar - Director
- Veerwala - Director
Anzil Meditech reported a net profit of ₹1.05 Cr (net margin 51.2%) and EBITDA of ₹1.48 Cr (EBITDA margin 72.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Anzil Meditech is 92% over three years. In the latest year (FY 2025) revenue rose 217%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Anzil Meditech is U93090UP2018PTC101146. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anzil Meditech was incorporated on 20 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Rajesh Kumar was appointed as Director on 20 Feb 2018. Rubi was appointed as Director on 20 Feb 2018. Veerwala was appointed as Director on 20 Feb 2018.
Yes, Anzil Meditech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Anzil Meditech can be reached through the website anzil.in. Its registered office is in Noida, Uttar Pradesh, India.